Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2025-02-19 2025-02-19
Drug Identification Number 02509253 02509253
Brand name BENDAMUSTINE HYDROCHLORIDE FOR INJECTION BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Common or Proper name BENDAMUSTINE HYDROCHLORIDE FOR INJECTION BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients BENDAMUSTINE HYDROCHLORIDE BENDAMUSTINE HYDROCHLORIDE
Strength(s) 25MG 25MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes Vial Vial
ATC code L01AA L01AA
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2023-03-31 2023-03-31
Estimated end date Unknown Unknown
Actual end date 2025-02-18 2025-02-18
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments This Product is available under Eugia Label. This Product is available under Eugia Label.
Health Canada comments